Glenna Mileson - Dec 28, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Financial Officer
Signature
/s/ Glenna Mileson
Stock symbol
ATHA
Transactions as of
Dec 28, 2022
Transactions value $
$144,341
Form type
4
Date filed
12/30/2022, 03:58 PM
Previous filing
Jun 24, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Award $2.09K +763 +0.7% $2.74 110K Nov 18, 2022 Direct F1, F2, F3
transaction ATHA Common Stock Purchase $142K +50K +45.48% $2.85 160K Dec 28, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of May 18, 2022 through November 18, 2022. This transaction is also exempt under Rule 16b-3(c).
F2 The Purchase Period ended November 18, 2022 and is the sole Purchase Period in the Offering Period (as defined in the ESPP) that began May 18, 2022.
F3 In accordance with the ESPP, these shares were purchased based on 85% of the closing price on November 18, 2022.
F4 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.93 to $2.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.